Use access key #2 to skip to page content.
$56.35 -0.55 (-0.97%)
9/5/2008 4:00 PM

Gen-Probe, Inc. (GPRO)

CAPS Rating:
*****

The Company is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood.

View All Commentary (GPRO)

Recs

1

Avatar doggetla (68.42) Submitted: 3/24/08 6:49 PM : Outperform Start Price: $49.00 GPRO Score: 22.74

just "discovered" this stock, healthcare is the sector to be in during a recession.

Report this Post Replies: 0 | Reply

Featured Broker Partners